Megmar APARECIDA DOS SANTOS Carneiro

Dr. Megmar APARECIDA DOS SANTOS Carneiro


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
GSGrazielle Rosa da Costa e Silva
Grazielle Rosa da Costa e Silva
Winny Éveny Alves MouraWinny Éveny Alves Moura
Winny Éveny Alves Moura
KSKamila Cardoso dos Santos
Kamila Cardoso dos Santos
DGDavi Oliveira Gomes
Davi Oliveira Gomes
GBGabriela Nolasco Bandeira
Gabriela Nolasco Bandeira
SHEILA ARAUJO TELESSHEILA ARAUJO TELES
SHEILA ARAUJO TELES
The coronavirus disease 2019 (COVID-19) pandemic has changed the course of human history and killed millions of people worldwide. Its long-term consequences remain uncertain. This study aimed to describe the short- and long-term symptoms of COVID-19 among individuals in Goiás, central Brazil, who experienced acute mild or non-symptomatic SARS-CoV-2 infection during the first wave of the pandemic. This prospective cohort study included 110 healthcare workers, 18 safety workers, and 19 administrative support workers, who were followed up for 12 months after the onset of COVID-19. Most participants were healthy adult female healthcare professionals. At the onset of infection, the major symptoms were headache, myalgia, nasal congestion, cough, coryza, anosmia, ageusia, sore throat, fatigue, diarrhea, and dyspnea. Furthermore, 20.3% of the participants had three or more COVID-19 symptoms that persisted for at least 12 months. These included coryza, congestion, hair loss, sore throat, headache, myalgia, cough, memory loss, anosmia, and fatigue. This study revealed a high prevalence of persistent symptoms of COVID-19 in healthy individuals from central Brazil, which may present an additional burden on healthcare services. Further studies are required to investigate the sequelae of COVID-19 over periods greater than 12 months.

10 October 2023 in Viruses
Verified
Journal Article
Open access
PDF file
SHEILA ARAUJO TELESSHEILA ARAUJO TELES
SHEILA ARAUJO TELES
KCKarlla Antonieta Amorim Caetano
Karlla Antonieta Amorim Caetano
MCMegmar APARECIDA DOS SANTOS Carneiro
Megmar APARECIDA DOS SANTOS Carneiro
LVLivia Melo Villar
Livia Melo Villar
JSJeanne-Marie R. Stacciarini
Jeanne-Marie R. Stacciarini
RMRegina Maria Bringel Martins
Regina Maria Bringel Martins
A transversal study was conducted among 472 vulnerable individuals (recyclable waste pickers, immigrants and refugees, homeless individuals, as well as lesbian, gay, bisexual, and transexual individuals) in Goiânia City, the capital of the State of Goiás, Brazil, to investigate the prevalence of hepatitis E virus (HEV) infection. A total of 459 (97.2%) serum samples were tested for anti-HEV IgG and IgM antibodies using fully automated chemiluminescence immunoassays (Liaison® Murex Anti-HEV IgG and IgM assays, DiaSorin, Saluggia, Italy). Positive samples were tested for the presence of HEV RNA by a real-time polymerase chain reaction. A seroprevalence of 0.87% (95% confidence interval [CI]: 0.34–2.22) was found for anti-HEV IgG. Furthermore, anti-HEV IgM was detected in only one individual (0.22%; 95% CI: 0.04–1.22), who was also negative for HEV RNA. These findings revealed that HEV infection is infrequent in vulnerable individuals in Central Brazil, with low seroprevalence of past and recent HEV infections.

27 September 2024 in Viruses
Verified
Journal Article
Open access
PDF file
TMThaís Augusto Marinho
Thaís Augusto Marinho
MOMichele Tiemi Okita
Michele Tiemi Okita
RGRafael Guimarães
Rafael Guimarães
AZAna Laura de Sene Amâncio Zara
Ana Laura de Sene Amâncio Zara
KCKarlla Antonieta Amorim Caetano
Karlla Antonieta Amorim Caetano
RMRegina Maria Bringel Martins
Regina Maria Bringel Martins
This is the first systematic review and meta-analysis to estimate the prevalence of human T-lymphotropic virus 1 and 2 (HTLV-1 and 2) infections among immigrants and refugees worldwide. PubMed/MEDLINE, Scopus, EMBASE, Web of Science, and Virtual Health Library (VHL) databases were searched for studies published from their inception to 6 January 2023. A meta-analysis using a generalized linear mixed model with a random effect was performed for HTLV-1 and HTLV-2. Subgroup analyses were performed based on the decade of study, sample size, confirmatory methods, region of study, risk group, and region of origin. Of the 381 studies initially identified, 21 were included. The pooled prevalence of HTLV-1 and HTLV-2 was 1.28% (95% CI: 0.58, 2.81) and 0.11% (95% CI: 0.04, 0.33), respectively. HTLV-1 prevalence differed significantly by region of origin, with the highest prevalence among those from the Western Pacific Region (7.27%; 95% CI: 2.94, 16.83). The subgroup analysis also showed significant differences between the estimates of HTLV-1 considering the decade of study, sample size, and region of study. For HTLV-2, significant differences were shown in relation to sample size, confirmatory methods, and risk group. The higher HTLV-1 prevalence found deserves public health attention in immigrant and refugee-receiving non-endemic countries.

6 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
VCVanessa D. Costa
Vanessa D. Costa
ASALANNA CALHEIROS SANTOS
ALANNA CALHEIROS SANTOS
LSLucas Lima da Silva
Lucas Lima da Silva
WWWilian Jean Wiggers
Wilian Jean Wiggers
CICLAUDIA ALEXANDRA PONTES IVANTES
CLAUDIA ALEXANDRA PONTES IVANTES
OGon behalf of The Brazilian COVID-19 Research Group
on behalf of The Brazilian COVID-19 Research Group
Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is a rapid method that can replace RT-qPCR. A simple molecular assay for SARS-CoV-2 RNA detection in gold-standard diagnosis through swabs and alternative specimens such as saliva could be helpful in promoting genomic surveillance. A multicenter study was conducted to evaluate the RT-LAMP assay method as an alternative for the molecular detection of SARS-CoV-2 lineages in swab and saliva samples. A total of 350 swabs from individuals with (n = 276) or without (n = 74) COVID-19 tested by RT-qPCR were collected. Paired saliva was also collected from 90 individuals who had SARS-CoV-2 RNA that was detectable (n = 30) or undetectable (n = 60) via RT-qPCR. For the RT-LAMP methodology, six primers were used for ORF1 gene amplification. As for SARS-CoV-2 genotyping, 39 swabs had the whole genome sequenced by MinION. The sensitivity of RT-LAMP to the swab was 90.2%. For the swab samples with Ct ≤ 30, the sensitivity improved by 96%. Considering saliva with Ct ≤ 30 in RT-qPCR testing, the RT-LAMP sensitivity was 100%. The RT-LAMP specificity was 100% for both the swab and saliva samples. This RT-LAMP assay was capable of detecting all the SARS-CoV-2 lineages circulating in the Brazilian swab samples. The RT-LAMP method has significant potential for use in clinical routines since it was capable of detecting SARS-CoV-2 RNA in swab and saliva samples.

14 July 2022 in Viruses
Verified
Journal Article
Open access
PDF file
TMThaynara Lorrane Silva Martins
Thaynara Lorrane Silva Martins
GSGrazielle Rosa da Costa e Silva
Grazielle Rosa da Costa e Silva
CSCarla de Almeida Silva
Carla de Almeida Silva
DGDAVI OLIVEIRA GOMES
DAVI OLIVEIRA GOMES
BSBruno Vinícius Diniz e Silva
Bruno Vinícius Diniz e Silva
KCKarlla Antonieta Amorim Caetano
Karlla Antonieta Amorim Caetano
Introduction: Eliminating hepatitis B and C in immigrant and refugee populations is a significant challenge worldwide. Given the lack of information in Brazil, this study aimed to estimate the prevalence of infections caused by hepatitis B and C viruses and factors associated with hepatitis B in immigrants and refugees residing in central Brazil. Methods: An observational, cross-sectional, and analytical study was conducted from July 2019 to January 2020 with 365 immigrants and refugees. Hepatitis B was detected by a rapid immunochromatographic test, enzyme immunoassay, and chemiluminescence, and hepatitis C by rapid immunochromatographic test. Multiple analysis was used to assess factors associated with hepatitis B infection. Results: Of the participants, 57.8% were from Haiti and 35.6% were from Venezuela. Most had been in Brazil for less than 2 years (71.2%). The prevalence of HBV infection and exposure was 6.6% (95% CI: 4.5–9.6%) and 27.9% (95% CI: 23.6–2.8%), respectively, and 34% had isolated anti-HBs positivity. Reporting a sexually transmitted infection was statistically associated with HBV infection (OR: 7.8; 95% CI: 2.3–26.4). No participant with positive anti-HCV serology was found. Conclusions: The study showed that participants were outside the reach of prevention and control actions for hepatitis B. Therefore, public health strategies must be designed to reach, inform, and vaccinate this group.

21 May 2023 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
BOBrunna Rodrigues Msc de Oliveira
Brunna Rodrigues Msc de Oliveira
BSBruno Vinícius Msc Diniz e Silva
Bruno Vinícius Msc Diniz e Silva
KSKamila Cardoso Msc dos Santos
Kamila Cardoso Msc dos Santos
KCKarlla Antonieta Amorim Caetano
Karlla Antonieta Amorim Caetano
GMGiana Mota
Giana Mota
MCMegmar APARECIDA DOS SANTOS Carneiro
Megmar APARECIDA DOS SANTOS Carneiro
Background: Transgender women (TGW) are susceptible to the acquisition of sexually transmitted infections (STIs), including human papillomavirus (HPV). Nonetheless, the exact data for this population are scarce. We estimated HPV positivity at the anal, genital, and oral sites among TGW and also identified the related characteristics and behaviors that could be risk factors for HPV infection in a sample of TGW in Brazil. Furthermore, we characterized the site-specific HPV genotypes among those who were positive for HPV at these 3 sites. Methods: A cross-sectional study was conducted on TGW in Goiânia City (Central-Midwest region), Brazil, between April 2018 and August 2019. Respondent-driven sampling was applied for recruitment. Next, self-collected anal, genital, and oral samples were examined for HPV DNA using polymerase chain reaction (SPF-10 primer). Human papillomavirus genotypes were identified in 12 TGW. Results: In the TGW included in the study, the anal, genital, and oral HPV positivity values were 77.2% (95% confidence interval [CI], 67.3%–84.6%), 33.5% (95% CI, 26.1%–48.9%), and 10.9% (95% CI, 5.8%–17.0%), respectively. In addition, the majority of 12 participants who tested for HPV had multiple genotypes. HPV-52 was the most prevalent genotype identified at the anal (66.6%) and genital (40.0%) sites, whereas HPV-62 and HPV-66 were the most common at the oral site (25.0%). Conclusions: A high HPV positivity was observed among TGW. Therefore, additional epidemiological studies on HPV genotypes should generate health intervention information, including the prevention, diagnosis, and treatment of sexually transmitted infections.